Northwestern Mutual Wealth Management CO Cue Biopharma, Inc. Transaction History
Northwestern Mutual Wealth Management CO
- $112 Billion
- Q3 2024
A detailed history of Northwestern Mutual Wealth Management CO transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 2,500 shares of CUE stock, worth $2,700. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,500
Previous 500
400.0%
Holding current value
$2,700
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding CUE
# of Institutions
52Shares Held
14.1MCall Options Held
14.4KPut Options Held
2.6K-
Bleichroeder LP New York, NY5MShares$5.4 Million1.28% of portfolio
-
Slate Path Capital LP New York, NY2.4MShares$2.59 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.03MShares$2.19 Million0.0% of portfolio
-
Black Rock Inc. New York, NY757KShares$817,2740.0% of portfolio
-
Geode Capital Management, LLC Boston, MA509KShares$549,5330.0% of portfolio
About Cue Biopharma, Inc.
- Ticker CUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,381,700
- Market Cap $38.2M
- Description
- Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...